Brief: Coya Therapeutics, Inc. Announces Preclinical Data Supporting The Role Of Expanded Regulatory T Cells (Tregs) As Potential Disease-Modifying Treatment In An Animal Model Of Alzheimer’S Disease (Ad)26/01/2023 14:05